TransMedics Group, Inc. (TMDX) Average P/FCF Ratio
The current p/fcf ratio for TransMedics Group, Inc. (TMDX) is 18.84 as of Saturday, June 20, 2026, shown against its trailing averages.
Average P/FCF Ratio Chart
TMDX P/FCF Ratio Averages
P/FCF RATIO CURRENT
18.84
P/FCF RATIO TTM
104.61
P/FCF RATIO 3Y
104.61
P/FCF RATIO 5Y
104.61
P/FCF RATIO 10Y
104.61
P/FCF RATIO 15Y
104.61
P/FCF RATIO 20Y
104.61
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein